Scar News and Research

RSS

Stereotaxis to be featured prominently in 31st HRS

Stereotaxis' safety and efficacy in the treatment of patients with complex arrhythmias such as atrial fibrillation, ventricular tachycardia, and congenital heart defects will be featured prominently in the scientific program of the 31st Annual Heart Rhythm Scientific Sessions in Denver, Colorado. Eight podium presentations and eight posters will underscore the broad clinical leadership that Stereotaxis has achieved in the treatment of patients with complex cardiac arrhythmias.

13 May 2010

New Melody Transcatheter Pulmonary valve helps congenital heart defect patients avoid multiple surgeries

Congenital heart defects are the most common type of major birth defect in the U.S., affecting about 25,000 babies each year. Now, a new valve being used at the University of Michigan's C.S. Mott Children's Hospital Congenital Heart Center can help patients delay or avoid multiple surgeries.

13 May 2010

FDA approves St. Jude Medical's Unify CRT-D and Fortify ICD devices

St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval and first U.S. implants of its Unify™ cardiac resynchronization therapy defibrillator (CRT-D) and Fortify™ implantable cardioverter defibrillator (ICD). The new devices feature advanced battery technology and circuitry that allow for the smallest device footprint in the industry and rapid charge times, without any compromise in device longevity or power.

13 May 2010

Spectranetics to demonstrate new Laser Lead Extraction Simulation system at Heart Rhythm 2010

Spectranetics Corporation today announced it will showcase a new advanced Laser Lead Extraction Simulation system at the Heart Rhythm Society's (HRS) 31st Annual Scientific Sessions, Heart Rhythm 2010. The new simulation system is intended to augment traditional procedural training for physicians on laser-assisted lead extraction procedures by permitting hands-on practice with extraction tools and techniques in multiple case scenarios in a virtual operating environment.

12 May 2010

Capstone Therapeutics to continue to planned 12-month endpoints in AZX100 Phase 2a clinical trials

Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from the second of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. The clinical trial will continue to its planned 12-month endpoints.

12 May 2010

St. Jude Medical launches Promote Quadra CRT-D in Europe

St. Jude Medical, Inc., a global medical device company, today announced the European launch of its Promote Quadra™ cardiac resynchronization therapy defibrillator (CRT-D). The Promote Quadra CRT-D is the industry's first quadripolar pacing system, which offers physicians the ability to more effectively and efficiently manage the ever-changing pacing needs of patients with heart failure.

12 May 2010

Advanced radiation techniques treat head and neck cancer, reduce swallowing complications

Researchers at the University of Michigan Comprehensive Cancer Center have applied advanced radiation techniques for head and neck cancer to avoid treating critical structures that affect swallowing and eating.

11 May 2010

Osiris Therapeutics' Prochymal granted FDA Orphan Drug Designation

Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.

5 May 2010

New light-activated Photochemical Tissue Bonding technology helps treat battlefield injuries

Airmen's traumatic battlefield injuries may be more effectively treated by using a new light-activated technology developed as a result of research managed by Air Force Office of Scientific Research and supported by funds from the Office of the Secretary of Defense.

4 May 2010

Molecular imaging can help physicians identify aortic dissection: Research

According to research published in the May issue of The Journal of Nuclear Medicine, molecular imaging can help physicians identify aortic dissection-an often fatal blood vessel condition-and help guide treatment.

3 May 2010

Vitamin E effective in treating NASH: Study

Vitamin E has been shown effective in treating nonalcoholic steatohepatitis, an obesity-associated chronic liver disease that can lead to cirrhosis, liver cancer, and death. NASH also is related to or a part of type 2 diabetes, lipid disorders and cardiovascular disease.

3 May 2010

Head- and neck-cancer patients who continue to smoke during radiation therapy have poorer overall survival

Smokers who don't quit before radiation therapy for throat, mouth and other head and neck cancers fair significantly worse than those who do, research from the UC Davis Cancer Center has found.

28 Apr 2010

New key-hole bowel surgery for cancer with only four days hospital stay

Major bowel cancer surgery usually takes days to heal. In a new technique developed by Tasmanian surgeons, the recovery time for such surgeries can be halved.

26 Apr 2010

Successful full face transplant in a 22 hour long operation: Barcelona

In a recent development a team of 30 Spanish surgeons have succeeded in a World’s first full face transplant. The patient had accidentally injured a large part of his face with a shotgun five years ago. This had left him disfigured an unable to breathe, swallow or talk properly. He has undergone nine unsuccessful operations before this operation was planned. In this operation he received the whole of his facial skin, muscles, nose, lips, teeth and cheek bones from a donor in a 22 hour operation at the Vall d'Hebron University Hospital on 20th March. He is on his way to recovery now. This is not the first face transplant but the first full face transplant and also the most complex of its kind.

26 Apr 2010

Magen Medical Solutions announces successful implantation of SpineShield anti-adhesion device

Magen Medical Solutions Ltd., a medical device company developing unique anti-adhesion devices for orthopedic applications, is pleased to announce that it has successfully implanted its first product, the SpineShield, in three patients at a clinical site in Europe.

19 Apr 2010

Multinational phase II study: GS-9450 can reduce markers of liver damage in patients with NASH

Results from a multinational phase II study presented today at the International Liver CongressTM 2010 have shown that treatment with the caspase inhibitor GS-9450 can reduce markers of liver damage in patients with non-alcoholic steatohepatitis (NASH - the most serious form of non-alcoholic liver disease) as demonstrated by reduced levels of alanine and aspartate aminotransferases, hepatic enzymes that indicate cell damage.

17 Apr 2010

New nanotechnology biomedical therapy for joint injuries

Dr. Nirav A. Shah, MD, an orthopaedic sports medicine surgeon affiliated with Palos Community Hospital is the first to design a new nanotechnology biomedical therapy that promotes the growth of new, stronger cartilage to aid in the treatment of joint injuries.

16 Apr 2010

Successful stem cell therapy performed on CHF patients in Mexico

Bioheart, Inc. announced that treatment with stem cell therapy on two congestive heart failure (CHF) patients was performed successfully at the Hospital Angeles Tijuana, Mexico, through Bioheart's Center of Excellence program with Regenerative Medicine Institute.

15 Apr 2010

SAGES 2010: Covidien to showcase technological advancements in bariatric, colorectal and hernia surgery

Covidien, a leading global provider of healthcare products, will preview a variety of new devices and showcase some of the Company's most innovative tools for endoscopic surgery and soft tissue repair at the 2010 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) annual meeting held here.

13 Apr 2010

IZI Medical Products introduces Mammography Indicator Markers

IZI Medical Products today announced that the company has developed and begun distributing two new lines of flat mammography markers, which are being manufactured in the United States and sold worldwide under the brand, Mammography Indicator® Markers.

7 Apr 2010

Scar News and Research

Stereotaxis to be featured prominently in 31st HRS

New Melody Transcatheter Pulmonary valve helps congenital heart defect patients avoid multiple surgeries

FDA approves St. Jude Medical's Unify CRT-D and Fortify ICD devices

Spectranetics to demonstrate new Laser Lead Extraction Simulation system at Heart Rhythm 2010

Capstone Therapeutics to continue to planned 12-month endpoints in AZX100 Phase 2a clinical trials

St. Jude Medical launches Promote Quadra CRT-D in Europe

Advanced radiation techniques treat head and neck cancer, reduce swallowing complications

Osiris Therapeutics' Prochymal granted FDA Orphan Drug Designation

New light-activated Photochemical Tissue Bonding technology helps treat battlefield injuries

Molecular imaging can help physicians identify aortic dissection: Research

Vitamin E effective in treating NASH: Study

Head- and neck-cancer patients who continue to smoke during radiation therapy have poorer overall survival

New key-hole bowel surgery for cancer with only four days hospital stay

Successful full face transplant in a 22 hour long operation: Barcelona

Magen Medical Solutions announces successful implantation of SpineShield anti-adhesion device

Multinational phase II study: GS-9450 can reduce markers of liver damage in patients with NASH

New nanotechnology biomedical therapy for joint injuries

Successful stem cell therapy performed on CHF patients in Mexico

SAGES 2010: Covidien to showcase technological advancements in bariatric, colorectal and hernia surgery

IZI Medical Products introduces Mammography Indicator Markers

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News